binifibrate (Q12200764)

Biniwas (English)

14 October 2016

C₂₅H₂₃ClN₂O₇

1 reference

Biniwas (English)

14 October 2016

CC(C)(C(=O)OC(COC(=O)C1=CN=CC=C1)COC(=O)C2=CN=CC=C2)OC3=CC=C(C=C3)Cl

1 reference

Biniwas (English)

medical condition treated

14 October 2016

familial hyperlipidemia

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/9NGZ4GPE20

2 November 2018

reference URL

https://www.ncbi.nlm.nih.gov/pubmed/2104097

subject has role

hypolipidemic

1 reference

Medical Subject Headings

MeSH descriptor ID

C038877

InChI=1S/C25H23ClN2O7/c1-25(2,35-20-9-7-19(26)8-10-20)24(31)34-21(15-32-22(29)17-5-3-11-27-13-17)16-33-23(30)18-6-4-12-28-14-18/h3-14,21H,15-16H2,1-2H3

15 March 2018

Identifiers

InChI

1 reference

BFYRHDVAEJIBON-UHFFFAOYSA-N

Biniwas (English)

14 October 2016

2 references

Biniwas (English)

14 October 2016

ChEBI release 2020-09-01

CAS Registry Number

69047-39-8

2 references

Global Substance Registration System

UNII

9NGZ4GPE20

binifibrate (English)

BFYRHDVAEJIBON-UHFFFAOYSA-N

14 October 2016

InChIKey

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=69047-39-8

1 reference

2-{[2-(4-Chlorophenoxy)-2-methylpropanoyl]oxy}-1,3-propanediyl dinicotinate (English)

14 October 2016

1 reference

Biniwas (English)

14 October 2016

mapping relation type

exact match

1 reference

ChEBI release 2019-10-02

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

BINIFIBRATE (English)

14 October 2016

1 reference

inferred from InChIKey

1 reference

1 reference

DSSTOX compound identifier

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

Global Substance Registration System

UNII

9NGZ4GPE20